Trials / Completed
CompletedNCT06703372
Photobiomodulation In Treatment Of Xerostomia In Type Ii Diabetic Patients
Effectiveness Of Photobiomodulation In Treatment Of Xerostomia In Type Ii Diabetic Patients (A Randomized, Controlled Clinical Trial)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Hams Hamed Abdelrahman · Academic / Other
- Sex
- All
- Age
- 25 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Xerostomia is a major oral health problem that if not recognized and treated can have a significant effect on a patient's quality of life. It leads to difficulties with speech, swallowing and taste alteration. Pathological causes of xerostomia are divided into local and systemic factors. Local factors include smoking, salivary gland diseases and head and neck radiation therapy. Systemic factors include autoimmune diseases as Sjögren syndrome and hormonal disorders as Diabetes Mellitus. Photobiomodulation (PBM) previously known as Low Level Laser Therapy (LLLT) is the application of red and near infra-red light over injuries or lesions to improve wound and soft tissue healing, reduce inflammation and give relief for both acute and chronic pain. It also has grabbed the attention over the last few years as an effective treatment for xerostomia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Diode Laser 980 nm, 0.2W | diode laser will be used at an operating wavelength of 980 nm, with adoption of the due safety measures in all cases. Laser irradiation will be applied bilaterally to the skin over the area of the submandibular and parotid glands. Irradiation will be applied externally to the parotid gland on a continuous basis and likewise to the submandibular gland moving the laser very slowly over the gland zone |
| OTHER | Placebo Diode laser | the tip of the instrument will be sealed with blue rubber to prevent the passage of light |
Timeline
- Start date
- 2022-10-20
- Primary completion
- 2024-08-01
- Completion
- 2024-08-01
- First posted
- 2024-11-25
- Last updated
- 2024-11-25
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06703372. Inclusion in this directory is not an endorsement.